Abstract
The authors used the California Health Facilities Discharge data for 1984 and 1985 to compare retrospectively in-hospital morbidity and mortality of all 721 patients with rheumatoid arthritis versus all 8,859 patients with osteoarthritis who underwent a non-emergent, first-time, unilateral total hip arthroplasty. The lengths of hospitalization, in-hospital mortality rates, and incidences of post-operative complications were similar in the two groups except for higher rates of wound infection and wound dehiscence in the patients with rheumatoid arthritis and a higher rate of thromboembolic events in the osteoarthritis group. The short-term outcome of patients with rheumatoid arthritis appears comparable to that of patients with osteoarthritis.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
White RH. Preoperative evaluation of patients with rheumatoid arthritis. Semin Arthritis Rheum. 1985;14:287–99.
D’Arcy EJ, Fell RH. Anaesthesia in juvenile chronic polyarthritis.In Arden BP, Ansell BM, eds. Surgical management of juvenile chronic polyarthritis. London: Academic Press, 1978;63–74.
Lofgren RH, Montgomery WW. Incidence of laryngeal involvement in rheumatoid arthritis. N Engl J Med. 1962;267:193–5.
Scott RD, Turner RH. Femoral fracture in conjunction with total hip replacement. J Bone Joint Surg. 1975;57A:494–501.
Garner RW, Mowat AG, Hazelman BC. Wound healing after operations on patients with rheumatoid arthritis. J Bone Joint Surg. 1973;55B:134–43.
Schorn D, Mowat AG. Penicillamine in rheumatoid arthritis: wound healing, skin thickness, and osteoporosis. Rheumatol Rehab. 1977;16:273–9.
David DS, Grieco MH, Cashman P. Adrenal glucocorticosteroids after 20 years: a review of their clinically relevant consequences. J Chronic Dis. 1970;22:637–711.
Levin ML. Patterns of tubulo-interstitial damage associated with non-steroid antiinflammatory drugs. Semin Nephrol. 1988;8:55–61.
Butt JH, Barthel JS, Moore RA. Clinical spectrum of the upper gastrointestinal effects of non-steroidal anti-inflammatory drugs. Natural history, symptomatology and significance. Am J Med. 1988;84:5–14.
SAS User’s Guide: Statistics, version 5 edition. Cary, NC: SAS Institute, 1985.
Kleinbaum DG, Kupper LL, Morgenstern H. Epidemiologic research. Belmont, CA: Lifetime Learning, 1982.
Fleiss JL. Statistical methods for rates and proportions. New York: John Wiley and Sons, 1981.
Salvati EA, Hughes P, Lachiewicz P. Bilateral total hip-replacement arthroplasty in one stage. J Bone Joint Surg. 1978;60-A:640–4.
Poss R, Ewald FC, Thomas WH, Sledge CB. Complications of total hip replacement arthroplasty in patients with rheumatoid arthritis. J Bone Joint Surg. 1976;58A:1130–3.
Freeman PA, Lee P, Bryson TW. Total hip joint replacement in osteoarthrosis and polyarthritis. Clin Orthop. 1973;95:224–30.
Welch RB, Charnley CBE. Low-friction arthroplasty of the hip in rheumatoid arthritis and ankylosing spondylitis. Clin Orthop. 1970;72:22–32.
Coventry MB, Beckenbaugh RD, Nolan DR, Ilstrup DM. 2012 total hip arthroplasties: a study of postoperative causes and early complications. J Bone Joint Surg. 1974;56-A:273–84.
Arden GP, Taylor AR, Ansell BM. Total hip replacement using McKee-Faver prosthesis. Ann Rheum Dis. 1970;29:1–5.
Poss R, Maloney JP, Ewald FC, et al. Six- to 11-year results of total hip arthroplasty in rheumatoid arthritis. Clin Orthop. 1984;182:109–16.
Poss R, Thornhill TS, Ewald F, Thomas WH, Batte NJ, Sledge CB. Factors influencing the incidence and outcome of infection following total joint arthroplasty. Clin Orthop. 1984;182:117–26.
Harris WH, Salzman EW, Athanasoulis CA, Waltman AC, De Sanctis RW. Aspirin prophylaxis after total hip replacement. N Engl J Med. 1977;297:1246–9.
Harris WH, Athanasoulis CA, Waltman AC, Salzman EW. Prophylaxis of deep-vein thrombosis after total hip replacement. J Bone Joint Surg. 1985;67A:57–62.
Hampson WGJ, Harris FC, Lucas HK, Roberts PH. Failure of low-dose heparin to prevent deep-vein thrombosis after hip arthroplasty. Lancet. 1974;ii:795–7.
Hull RD, Raskob GE. Prophylaxis of venous thromboembolic disease following hip and knee surgery. J Bone Joint Surg. 1986;68-A:146–50.
Coventry MB, Nolan DR, Beckenbaugh RD. “Delayed” prophylactic anticoagulation: a study of results and complications in 2,012 total hip arthroplasties. J Bone Joint Surg. 1973;55-A:1487–92.
Kelsey JL, Wood PNH, Charnley J. Prediction of thromboembolism following total hip replacement. Clin Orthop. 1976;114:247–58.
Sikorski JM, Hampson WG, Staddon GE. The natural history and aetiology of deep vein thrombosis after total hip replacement. J Bone Joint Surg. 1981;63-B:171–7.
Hill H, Hill A, Taylor AR. Deep vein thrombosis and rheumatoid arthritis. Ann Rheum Dis. 1978;37:293.
Medsger TA, Masi AT. Epidemiology of the rheumatic diseases.In McCarty DJ, ed. Arthritis and allied conditions. Philadelphia: Lea & Febiger, 1985;9–13.
Hoaglund FT, Yan ACMC, Wong WL. Osteoarthritis of the hip and other joints in Southern Chinese in Hong Kong. J Bone Joint Surg. 1973;55A:545–57.
Peyron JG. The epidemiology of osteoarthritis.In Moskowitz RM, Howell DS, Goldberg VM, Mankin HJ, eds. Osteoarthritis, diagnosis and management. Philadelphia: W. B. Saunders, 1984;9–27.
Author information
Authors and Affiliations
Additional information
Received from the Departments of Internal Medicine and Orthopedic Surgery, University of California, Davis, California.
Presented in part at the annual meeting of the American Rheumatism Association, Houston, Texas, June 1988.
Rights and permissions
About this article
Cite this article
White, R.H., McCurdy, S.A. & Marder, R.A. Early morbidity after total hip replacement. J Gen Intern Med 5, 304–309 (1990). https://doi.org/10.1007/BF02600396
Issue Date:
DOI: https://doi.org/10.1007/BF02600396